Site Map
Pages
- The Ming Hsieh Institute
- About Ming Hsieh
- Funding
- Investigators
- Research
- The Institute
- Digital Accessibility
- Privacy Policy
- Notice of Non-discrimination
- Site Map
Posts by category
- Category: 2011
- Diagnostic imaging of smart genetically engineered nanomedicines
- Telomerase Reprogramming Nanoparticles (TeRN): Design and Validation of a Universal Cancer Therapeutic
- An Ultrasound-Activated Nanoparticle Vehicle for Selective Imaging and Drug Delivery
- Engineering Nanoparticles for Enhanced Cancer Therapeutics
- Category: 2012
- Optimization of pH-sensitive peptide nanoconstructs for use in targeting the mildly acidic tumor microenvironment
- Multiplexed Polysilicon Nanoribbon Sensors for Therapeutic Monitoring and Detection of Brain Cancer
- Scintillating Nanoparticles for Radiosensitization of Cancer Cells
- Targeted Nanoparticle Therapy for Ewing’s Sarcoma
- Targeting the Mildly Acidic Tumor Microenvironment using pH-sensitive Recombinant Peptide Nanoconstructs
- Category: 2013
- Category: 2014
- Bispecific hybrid nanoworms for immunotherapy of B-cell lymphoma
- Metal Oxide Nanoribbon Biosensor Chips for Point of Care Diagnosis
- Nanoparticle-mediated delivery targeting TAK1 as a metastatic breast cancer therapy
- Nanoparticle-enhanced ultrasound therapy
- Focused microwave cancer therapy using lithographically defined nanoparticles
- Category: 2015
- Development of a nano-encapsulated biomimetic small molecule therapeutic for the treatment of colon cancer
- Nanoparticle Formulations of Mas Agonists for Adjuvant to Cancer Chemotherapy
- Engineering Exosome Nanoparticles for Targeted Cancer Therapies
- Multifunctional Gold Nanostars for CD13-Targeted Tumor Imaging and Photothermal Therapy
- Nanoscale parenteral formulations of a small molecule therapeutic for the treatment of resistant breast cancer
- Category: 2016
- Category: 2017
- Integrating Spatiotemporal Single Cell Proteogenomics Data from Liquid Biopsies in Patients with Head and Neck Cancer
- Machine Learning Applications to the Immunology of Melanoma
- Developing Novel Immuno-nanoparticles for Colorectal Cancer
- Imaging Mass Cytometry to Profile Tumor Immune Microenvironment
- Development of a Nano-Encapsulated Small Molecule Immunotherapeutic for Colon Cancer
- Large-scale Isolation of Cytotoxic Extracellular Vesicles from Activated Natural Killer Cells for Immunotherapy of Cancer
- Category: 2018
- Immunomodulatory and Cytotoxic Micelles for Prostate Cancer
- Chimeric Antigen Receptor Engineered Natural Killer Cells as a Carrier of Drug-Encapsulated Nanoparticles Targeting Adenosine Receptors in Ovarian Cancer
- Characterizing the immune microenvironment of lymphoma and myeloma using multiplexed imaging mass cytometry
- Next Generation CD19 CAR-T for the treatment of lymphoid malignancies
- Category: 2019
- Determining Predictors of Response to Oncolytic Virus Immune Priming
- Establishing a Diagnosis of Lung Cancer Through a Fluid Biopsy
- The Development of huLym-1DAPCAR-T Cells for B-cell Lymphoma Therapy
- The Geochemistry of Cancer: A New Collaborative Approach for Research and Diagnosis
- Pilot feasibility study to evaluate the immunomodulatory effects of FID-007 at two dose levels in patients with solid tumors
- First Small Molecule Therapy for Retinal Degenerations
- In Vivo Validation of a Smart Hydrocephalus Shunt
- Next Generation CD19 CAR-T for the treatment of lymphoid malignancies
- Category: 2020
- Developing High Affinity Peptides to Target SARS-CoV-2 Spike (S) Protein
- First Small Molecular for Retinal Degenerations
- Engineering natural killer cells to target HLA-DR-negative hematologic malignancies
- Targeting CD99 and FLT3 to eliminate leukemia stem cells (LSCs) in Acute Myeloid Leukemia
- Novel Dynamic PET Kinetics and MRI Radiomics Analyses in Brain Tumors
- DSCR1, anti-angiogenesis drug target against solid tumors with focus on colorectal cancer
- Novel Deep Learning Techniques for Imputing Medical Images: Application in Clinical Management of Renal Masses
- Category: 2021
- A next-generation MR-Linac imaging strategy for abdominal MR-guided radiotherapy
- Developing novel immunotherapy for colorectal cancer
- Development of a novel multimodal molecular imaging approach to guide intra operative tumor resection and post-operative treatment planning
- Image enhancement for low-field MRI
- Molecular imaging of lymph node metastases in prostate cancer using targeted nanoparticles
- Developing novel chimeric antigen receptor T cells for treating post-transplant relapse of acute leukemia
- Minimally Invasive, Bioengineered Neuro-Modulation for Neuroprotection and Neuro-regeneration
- Developing anti-SEMA4D antibody drug conjugate to prevent breast cancer to brain metastasis
- Category: 2022
- Oncology Decision Support in Ovarian Cancer: Artificial Intelligence Based Pathomics to Identify Platinum Resistant Epithelial Ovarian Cancer
- An Ultrasound Activated Ultrasound Contrast Agent for Urinary Imaging
- Improving Immunotherapy in Breast Cancer Using Computational Modeling
- Liquid Biopsy Predicts Metastatic Relapse in Primary Bladder Cancer Patients
- Low-Cost “Smart” mHealth System for Predicting Future Likelihood of Vaso-Occlusive Pain Crisis: Moving Towards Personalized Medicine in Sickle Cell Disease
- Therapeutic Application of Urinary Extracellular Vesicles for Autosomal Dominant Polycystic Kidney Disease
- Category: 2023
- Development of Novel Antibody-Drug Conjugates for Metastatic Breast Cancer
- Innovative Ultrasound-Guided CAR-Macrophages for Safe and Effective Cancer Immunotherapy
- Controllable CAR T Cell Therapy by Focused Ultrasound for Pediatric Glioblastoma
- Window pre-operative study of taxane chemotherapy in patients with squamous cell carcinoma of the head and neck
- INTERCEPT: Data Science-Driven Liquid Biopsy in Early Breast Cancer Detection
- Development of genome-guided immunotherapeutic strategies for head neck cancer
- Pharmacological targeting of pyrimidine pathway to modulate response to checkpoint inhibition in metastatic colorectal cancer
- Targeting circadian clock proteins for novel therapeutics to treat Acute Myeloid Leukemia
- Therapeutic Targeting of Hdm2/HdmX E3 Ligase in CRC